Q1 2024 Holdings
Filed 2024-05-15 | 26 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $247.7M | 10,473,913 | 19.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $202.5M | 2,697,267 | 16.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $89.8M | 2,992,028 | 7.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $82.0M | 1,317,213 | 6.6% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $78.6M | 3,163,868 | 6.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $76.3M | 3,303,381 | 6.1% |
| Savara Inc(SVRA) | COM | 805111101 | $72.5M | 14,565,457 | 5.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $62.4M | 8,703,268 | 5.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $53.7M | 4,034,582 | 4.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $52.6M | 196,995 | 4.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $38.8M | 8,663,673 | 3.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $27.6M | 1,617,364 | 2.2% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $23.5M | 16,915,784 | 1.9% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $23.0M | 2,892,663 | 1.8% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $19.9M | 2,011,687 | 1.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $16.6M | 1,132,397 | 1.3% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $14.7M | 2,749,808 | 1.2% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $12.6M | 1,393,380 | 1.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $10.0M | 2,485,638 | 0.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $9.3M | 1,142,210 | 0.8% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $8.2M | 8,434,560 | 0.7% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $8.0M | 1,799,595 | 0.6% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $5.9M | 2,000,000 | 0.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.7M | 3,000,000 | 0.3% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $3.0M | 2,805,413 | 0.2% |
| Newamsterdam Pharma Company | *W EXP 99/99/999 | N62509117 | $1.1M | 100,000 | 0.1% |